These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 310362)

  • 1. Preparation and laboratory testing of plain and aluminum hydroxide-adsorbed cholera vaccines used in a field trial in Indonesia.
    Joó I; Csizér Z
    Bull World Health Organ; 1978; 56(4):615-8. PubMed ID: 310362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenicity testing of plain and aluminium hydroxide-adsorbed whole-cell cholera vaccines.
    Joó I
    Acta Trop; 1979 Jun; 36(2):151-6. PubMed ID: 41423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973--75.
    Saroso JS; Bahrawi W; Witjaksono H; Budiarso RL; Brotowasisto ; Bencić Z; Dewitt WE; Gomez CZ
    Bull World Health Organ; 1978; 56(4):619-27. PubMed ID: 365388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation.
    Mosley WH; Aziz KM; Rahman AS; Chowdhury AK; Ahmed A
    Bull World Health Organ; 1973; 49(4):381-7. PubMed ID: 4604478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A test of antigenicity for the selection of strains for inclusion in cholera vaccines.
    Finkelstein RA; Pongpairojana S
    Bull World Health Organ; 1968; 39(2):247-59. PubMed ID: 5303406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled field trial of the effectiveness of monovalent classical and El Tor cholera vaccines in the Philippines.
    Philippines Cholera Committee
    Bull World Health Organ; 1973; 49(1):13-9. PubMed ID: 4596491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of potency of inactivated cholera vaccine by mouse protection assay & antibody induction method.
    Sood A; Sokhey J; Sharma SB; Gairola S; Singh S; Singh H
    Indian J Med Res; 1994 Dec; 100():262-5. PubMed ID: 7829163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled field trial of an aluminum phosphate-adsorbed cholera vaccine in Calcutta.
    Pal SC; Deb BC; Sen Gupta PG; De SP; Sircar BK; Sen D; Sikdar SN
    Bull World Health Organ; 1980; 58(5):741-5. PubMed ID: 7028299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to plain and adsorbed cholera vaccines.
    Joó I; Csizér Z; Juhász VP
    Prog Immunobiol Stand; 1971; 5():350-4. PubMed ID: 4633963
    [No Abstract]   [Full Text] [Related]  

  • 11. A duplex vibriocidal assay to simultaneously measure bactericidal antibody titers against Vibrio cholerae O1 Inaba and Ogawa serotypes.
    Yang JS; Choi S; Kim DD; Kang SS; Yun CH; Lee K; Han SH
    J Microbiol Methods; 2009 Dec; 79(3):289-94. PubMed ID: 19796659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serological response in man to an anticholera vaccine made from killed vibrios and partially purified with aluminium hydroxide].
    Soscia M; Saletti M; Ricci A; Di Gioia M
    Ann Sclavo; 1975; 17(3):257-66. PubMed ID: 1230039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and laboratory tests of oil-adjuvant cholera vaccine.
    Ogonuki H; Hashizume S; Takashashi B
    Bull World Health Organ; 1967; 37(5):729-36. PubMed ID: 5300875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
    Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant effect of DEAE-dextran on cholera vaccines.
    Joó I; Emöd J
    Vaccine; 1988 Jun; 6(3):233-7. PubMed ID: 2458658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The current status of research on a cholera vaccine].
    Fournier JM
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):412-5. PubMed ID: 10078377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.